Brian Berger
Retina Specialist · Austin, TXNPI 1649257312
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (35.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boehringer Ingelheim International GmbH at 33.1% of the total. 2025 is the largest year on record at $17,369, 2.2 times the $7,775 reported in 2019. Among retina specialist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $395.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$12K
- Boehringer Ingelheim$7K
- Roche TCRC, Inc.$4K
- F. Hoffmann-la Roche AG$4K
- Boehringer Ingelheim Pharma GmbH & Co.kg$3K
- Genentech, Inc.$2K
- plus $4K from 12 others
Across 1,048 payments — averaging $7298.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$4.1M
- Roche TCRC, Inc.$2.4M
- AstraZeneca$466K
- Boehringer Ingelheim$177K
- Eyepoint US, Inc.$124K
- Boehringer Ingelheim International GmbH$121K
- plus $240K from 8 others
What the payments were for
- Consulting fees$11,68633%
- Speaking & faculty fees$6,88219%
- Travel & lodging$12,53135%
- Food & beverage$4,48913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 8 | $11,765 |
| Boehringer Ingelheim | 12 | $6,989 |
| Roche TCRC, Inc. | 8 | $4,062 |
| F. Hoffmann-la Roche AG | 3 | $3,731 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $3,325 |
| Genentech, Inc. | 16 | $1,941 |
| Kyowa Kirin, Inc. | 9 | $1,810 |
| Novartis | 16 | $962 |
| Regeneron | 2 | $213 |
| Heidelberg Engineering, Inc. | 1 | $184 |
| Optos, Inc. | 2 | $182 |
| Eyepoint US, Inc. | 2 | $160 |
| Biotissue Holdings Inc. | 1 | $124 |
| Astellas Pharma Global Development | 2 | $49 |
| AbbVie(2 entities) | 2 | $40 |
| Genentech USA, Inc. | 1 | $21 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| Spark Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$8,443
- BEOVU$569
- Lucentis$270
- Spectralis$184
- EYLEA HD$150
- SUSVIMO$146
- VABYSMO$146
- YUTIQ$145
- Prokera$124
- AmnioGraft$124
How this compares
$35,588 in reported general payments places this provider in the 90th percentile of 108 retina specialist providers in Texas.
Other retina specialist in Austin
- Isaac LooseAustin$4K
- Cecilia SanchezAustin$3K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.